Busch Matthew C. 4
4 · AMGEN INC · Filed Mar 5, 2025
Insider Transaction Report
Form 4
AMGEN INCAMGN
Busch Matthew C.
VP, Finance & CAO
Transactions
- Award
Common Stock
2025-03-03+497→ 5,277 total
Footnotes (1)
- [F1]These shares include 100 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.